Overview

TPA in Acute Stroke With COVID Verus Non-COVID-19 Patients

Status:
Not yet recruiting
Trial end date:
2022-09-15
Target enrollment:
Participant gender:
Summary
The investigator will recruit consecutively all patients coming with acute ischemic stroke either with or without COVID -19 infection and suitable for IV injection with Tissue plasminogen activators according to guideline and inclusion criteria of tPA. Aswan University Hospital.
Phase:
Phase 1
Details
Lead Sponsor:
Assiut University
Collaborator:
Aswan University Hospital
Treatments:
Plasminogen
Tissue Plasminogen Activator